[关键词]
[摘要]
目的 研究膜翅目昆虫提取物Ento-Ⅱ涂膜剂的镇痛及活血化瘀作用,为相关药物的开发提供科学依据。方法 采用经典热板法和扭体法作为镇痛实验模型,观察Ento-Ⅱ涂膜剂对小鼠的镇痛作用;大鼠sc大剂量盐酸肾上腺素后,施以冰水浸泡制备急性血瘀模型,采用线栓法复制大鼠局灶性脑缺血再灌注损伤模型,测定血液流变学相关指标。结果 在镇痛实验中,与对照组比较,Ento-Ⅱ涂膜剂20、10、5 mg/kg能显著延长小鼠给药后30、60、90 min的痛阈值,明显减少小鼠15 min内的扭体次数,显著延长小鼠扭体的潜伏期(P<0.01)。在血瘀合并脑缺血实验中,与模型组比较,Ento-Ⅱ涂膜剂6.67、3.33、1.67 mg/kg组24 h时大鼠神经功能评分和全血黏度显著降低(P<0.01);3.33 mg/kg组大鼠血浆黏度和红细胞聚集指数显著降低(P<0.05);6.67、3.33 mg/kg组大鼠卡松黏度显著降低(P<0.01)。结论 Ento-Ⅱ涂膜剂具有明显的镇痛作用和活血化瘀作用。
[Key word]
[Abstract]
Objective To study the analgesic, activating blood and resolving stasis effect of Ento-Ⅱ plastic.Methods Hot plate procedure and torsion body method were used as analgesic experimental model to observe the analgesic effect of Ento-Ⅱ plastic.The acute blood stasis rats experimental model was established through rat subcutaneous injection of high-dose adrenaline hydrochloride and soaked in ice water.Then, the blood stasis focal cerebral ischemia-reperfusion models were established by suture method on the rats.The hemorrheologic indicators were determined.Results Compared with control group, Ento-Ⅱ plastic could significantly prolong pain thresholds in mice at 30, 60, and 90 min after final administration (P < 0.01).Ento-Ⅱ plastics 20, 10, and 5 mg/kg dose groups could reduce aceticacid-induced mice writhing times and prolong the incubation period (P < 0.01).The experimental result of rats blood stasis focal cerebral ischemia-reperfusion at 24 h after reperfusion showed that Ento-Ⅱ plastics 6.67, 3.33, and 1.67 mg/kg dose groups could obviously reduce the neurological function score and whole blood viscosity (P < 0.01).3.33 mg/kg dose group could significantly reduce plasma viscosity, erythrocyte aggregation index, and casson viscosity (P < 0.05).The effect were similar to that of ligustrazine.6.67 and 3.33 mg/kg dose groups could significantly reduce casson viscosity (P < 0.01).Conclusion Ento-Ⅱ plastic has obvious analgesic effect and activating blood and resolving stasis effect.
[中图分类号]
[基金项目]
国家自然科学基金资助项目:景颇族传统昆虫药物胡蜂蜂毒对大鼠MCAO/R后BBB的保护作用及其潜在机制探索(81703742);云南省应用基础研究重点项目:胡蜂蜂毒抗脑缺血活性及相关物质基础比较研究(2017FA050)